JP Morgan Chase’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-8,978
| Closed | -$41K | – | 6165 |
|
|
2019
Q1 | $41K | Sell |
8,978
-77,374
| -90% | -$366K | ﹤0.01% | 5205 |
|
|
2018
Q4 | $302K | Buy |
86,352
+78,156
| +954% | +$543K | ﹤0.01% | 4389 |
|
|
2018
Q3 | $83K | Buy |
8,196
+996
| +14% | +$7.95K | ﹤0.01% | 5026 |
|
|
2018
Q2 | $53K | Sell |
7,200
-18,424
| -72% | -$128K | ﹤0.01% | 5061 |
|
|
2018
Q1 | $155K | Buy |
25,624
+19,273
| +303% | +$159K | ﹤0.01% | 4452 |
|
|
2017
Q4 | $61K | Sell |
6,351
-51,203
| -89% | -$335K | ﹤0.01% | 4833 |
|
|
2017
Q3 | $508K | Buy |
57,554
+4,231
| +8% | +$43.7K | ﹤0.01% | 3825 |
|
|
2017
Q2 | $674K | Buy |
53,323
+7,629
| +17% | +$90.3K | ﹤0.01% | 3607 |
|
|
2017
Q1 | $480K | Buy |
45,694
+12,561
| +38% | +$134K | ﹤0.01% | 3725 |
|
|
2016
Q4 | $305K | Buy |
33,133
+33,095
| +87,092% | +$374K | ﹤0.01% | 3992 |
|
|
2016
Q3 | $0 | Sell |
38
-50
| -57% | -$760 | ﹤0.01% | 4966 |
|
|
2016
Q2 | $1K | Sell |
88
-119
| -57% | -$1.73K | ﹤0.01% | 4721 |
|
|
2016
Q1 | $3K | Sell |
207
-227,612
| -100% | -$4.32M | ﹤0.01% | 4485 |
|
|
2015
Q4 | $6.52M | Sell |
227,819
-76,098
| -25% | -$2.11M | ﹤0.01% | 2062 |
|
|
2015
Q3 | $8.65M | Buy |
303,917
+68,771
| +29% | +$2.53M | ﹤0.01% | 1871 |
|
|
2015
Q2 | $8.45M | Buy |
235,146
+109,588
| +87% | +$3.41M | ﹤0.01% | 2044 |
|
|
2015
Q1 | $3.65M | Buy |
125,558
+97,010
| +340% | +$2.57M | ﹤0.01% | 2547 |
|
|
2014
Q4 | $601K | Buy |
+28,548
| New | +$565K | ﹤0.01% | 3597 |
|
|
2013
Q4 | – | Sell |
-484,644
| Closed | -$5.65M | – | 4334 |
|
|
2013
Q3 | $5.65M | Sell |
484,644
-674,943
| -58% | -$5.54M | ﹤0.01% | 2107 |
|
|
2013
Q2 | $5.35M | Buy |
+1,159,587
| New | +$4.25M | ﹤0.01% | 2096 |
|
Other funds holding INSY
WS
JP Morgan Chase's INSY Position: Q2 2019 in Review
JP Morgan Chase sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 8,978 shares — an estimated $41K sold.
JP Morgan Chase first reported a position in INSY in Q2 2013 and held it in 20 quarters. The position peaked at $8.65M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- JP Morgan Chase reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- JP Morgan Chase sold 8,978 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $41K.
- JP Morgan Chase first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 20 quarters.
- JP Morgan Chase's Insys Therapeutics, Inc. position peaked at $8.65M in Q3 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.